Related references
Note: Only part of the references are listed.The role of WNT10B in physiology and disease
P. Wend et al.
ACTA PHYSIOLOGICA (2012)
Wnt5a: its signalling, functions and implication in diseases
A. Kikuchi et al.
ACTA PHYSIOLOGICA (2012)
FHL2 exhibits anti-proliferative and anti-apoptotic activities in liver cancer cells
Chor-Fung Ng et al.
CANCER LETTERS (2011)
Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1
Wenjing Zhang et al.
EUROPEAN JOURNAL OF CANCER (2011)
The Wnt signaling pathway: implications for therapy in osteosarcoma
Peter McQueen et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer
Lucia Gullotti et al.
LABORATORY INVESTIGATION (2011)
High Wnt Signaling Represses the Proapoptotic Proteoglycan syndecan-2 in Osteosarcoma Cells
Francois-Xavier Dieudonne et al.
CANCER RESEARCH (2010)
FoxO-Mediated Defense against Oxidative Stress in Osteloblasts, Is Indispensable for Skeletal Homeostasis in Mice
Elena Ambrogini et al.
CELL METABOLISM (2010)
Deficiency of the LIM-Only Protein FHL2 Reduces Intestinal Tumorigenesis in Apc Mutant Mice
Charlotte Labalette et al.
PLOS ONE (2010)
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
Maya Kansara et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
M. Enomoto et al.
ONCOGENE (2009)
Wnt signaling control of bone cell apoptosis
Peter V. N. Bodine
CELL RESEARCH (2008)
Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins
Jung Park et al.
FASEB JOURNAL (2008)
FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β-catenin signaling-dependent Runx2 expression
Zahia Hamidouche et al.
FASEB JOURNAL (2008)
The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities
Ming Li et al.
GLIA (2008)
Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion
Olivia Fromigue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation
Charlotte Labalette et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival
Kevin Chen et al.
PEDIATRIC BLOOD & CANCER (2008)
Involvement of MET/TWIST/APC combination or the potential role of ossification factors in pediatric high-grade osteosarcoma oncogenesis
Natacha Entz-Werle et al.
NEOPLASIA (2007)
FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells
Bernd T. Martin et al.
CELL CYCLE (2007)
Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis
Jide Wang et al.
GASTROENTEROLOGY (2007)
Molecular pathogenesis of osteosarcoma
Maya Kansara et al.
DNA AND CELL BIOLOGY (2007)
RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation
O. Fromigue et al.
CELL DEATH AND DIFFERENTIATION (2006)
Wnt signaling and osteoblastogenesis
Peter V. N. Bodine et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2006)
The multifunctional roles of the four-and-a-half-LIM only protein FHL2
M Johannessen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT
M Almeida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression
T Gaur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts
T Günther et al.
EMBO JOURNAL (2005)
Hematogenous micrometastases in osteosarcoma patients
OS Bruland et al.
CLINICAL CANCER RESEARCH (2005)
Functional interaction between β-catenin and FOXO in oxidative stress signaling
MAG Essers et al.
SCIENCE (2005)
Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate
M Kinoshita et al.
INTERNATIONAL JOURNAL OF UROLOGY (2005)
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation
YH Yang et al.
EMBO JOURNAL (2005)
Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes
NH Purcell et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and β-catenin
C Labalette et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1
A Morlon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of the LIM protein FHL2 as a coactivator of β-catenin
Y Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cytoplasmic and/or nuclear accumulation of the β-catenin protein is a frequent event in human osteosarcoma
RC Haydon et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The LIM-only protein FHL2 interacts with β-catenin and promotes differentiation of mouse myoblasts
B Martin et al.
JOURNAL OF CELL BIOLOGY (2002)
Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2)
YG Amaar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus
JM Müller et al.
EMBO JOURNAL (2002)
DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis
FA Scholl et al.
JOURNAL OF CELL BIOLOGY (2000)
The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several α and β integrin chains and is recruited to adhesion complexes
V Wixler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein
H Tanahashi et al.
HUMAN MOLECULAR GENETICS (2000)
FHL2, a novel tissue-specific coactivator of the androgen receptor
JM Müller et al.
EMBO JOURNAL (2000)
An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential
C Khanna et al.
CLINICAL & EXPERIMENTAL METASTASIS (2000)